Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Ophthalmic Plastic and Reconstructive Surgery|February 20, 2026
Relapse Versus Rebound in Thyroid Eye Disease After Teprotumumab Treatment: A Retrospective Case SeriesJulie M Shabto, Amy Shteyman, Shanlee Stevens, et al.Urology|February 26, 2022
Access to Care for Infertile Men: Referral Patterns of Fertility Clinics in the United StatesJulie M Shabto, Dattatraya Patil, Katherine Poulose, et al.Urology Practice|May 5, 2023
Referral Patterns for Infertile Men: Predictors of Continued Treatment by Reproductive Endocrinologist versus Referral to a Nearby UrologistJulie M Shabto, Dattatraya Patil, Katherine Poulose, et al.Journal of Pediatric Ophthalmology and Strabismus|July 24, 2024
Pediatric-Type Follicular Lymphoma of the Conjunctiva in Two AdolescentsJulie M Shabto, Alejandro A Gru, Craig R Soderquist, et al.The Oncologist|December 24, 2025
Baseline geriatric 8 (G8) screening tool predicts overall survival in metastatic urothelial carcinoma treated with immune checkpoint inhibitorsChristopher H Rhee, Subir Goyal, Yuan Liu, et al.The Oncologist|March 13, 2020
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsDylan J Martini, Yuan Liu, Julie M Shabto, et al.Cancer Treatment and Research Communications|May 24, 2021
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinibDylan J Martini, Meredith R Kline, Yuan Liu, et al.Cancer Medicine|February 27, 2020
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitorsJulie M Shabto, Dylan J Martini, Yuan Liu, et al.Clinical Genitourinary Cancer|December 19, 2021
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma PatientsDylan J Martini, Sean T Evans, Yuan Liu, et al.Journal for Immunotherapy of Cancer|July 30, 2021
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitorsJacqueline T Brown, Yuan Liu, Julie M Shabto, et al.Pageof 3